Fundraising FoxBlueRun Ventures — 2023 Investments
6 investments dated 2023 · listed companies and verified rows first · show all
Cionic develops the Neural Sleeve, an FDA-cleared wearable device that uses electrical muscle stimulation to improve walking and mobility for people with neurological conditions including Multiple Sclerosis, stroke, cerebral palsy, and spinal cord injury.
HardwareHealthtechMedical DevicesSan Francisco, US
Jeremiah Robison(Executive Officer, Director)in
Board seatJohn Malloy· per SEC Form D
Co-investorsEnable VenturesEPIC VENTURESJobsOhio VenturesLDV CapitalL Catterton
Chain Reaction designs processors, including its 3PU FHE processor, that make fully homomorphic encryption practical for large-scale computation on encrypted data.
CybersecurityHardwareSemiconductors
Alon Webman(Founder)in
Co-investorsGlobal Blockchain VenturesHanaco Venture CapitalAtreides ManagementExorJVPMorgan Creek Capital
Verismo is a biopharmaceutical company founded by the inventors of Kymriah, the first FDA-approved CAR T cell therapy, developing next-generation CAR T therapies using KIR receptor technology to address limitations in first-generation approaches.
BiotechDeep TechHealthtechMedical DevicesPhiladelphia, US
Bryan Kim(Co-Founder and CEO/President)inGene Kim(Executive Officer)in
BoardJong Sun Yoon(Director)Dong Gun Kim(Director)Yang Gon Jin(Director)
Co-investorsBRV Capital Management
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.